Jiangsu Kanion Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001CL7
CNY
15.10
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,837.10
4,789.01
4,277.70
3,587.77
2,986.46
4,491.07
3,749.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,837.10
4,789.01
4,277.70
3,587.77
2,986.46
4,491.07
3,749.11
Raw Material Cost
1,136.11
1,345.42
1,288.41
1,105.93
903.61
1,087.13
992.01
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
422.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.13
23.95
2.46
11.79
23.88
39.41
48.01
Selling and Distribution Expenses
1,806.89
2,237.15
2,010.77
1,686.91
1,397.20
2,399.39
1,986.62
Other Expenses
56.60
77.83
57.77
46.46
33.43
37.15
-21.31
Total Expenditure (Excl Depreciation)
3,532.10
4,384.86
3,879.37
3,269.20
2,659.04
3,897.46
3,235.63
Operating Profit (PBDIT) excl Other Income
305
404.20000000000005
398.29999999999995
318.6
327.40000000000003
593.6
513.5
Other Income
119.49
65.28
49.28
19.99
-11.94
27.98
13.93
Operating Profit (PBDIT)
616.49
675.16
641.62
531.11
478.99
782.15
692.76
Interest
23.13
23.95
2.46
11.79
23.88
39.41
48.01
Exceptional Items
-3.85
-2.65
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,700.99
3,443.59
2,989.29
2,481.85
2,082.86
3,403.94
2,757.10
Depreciation
204.76
200.59
193.48
191.08
160.71
167.38
166.09
Profit Before Tax
384.75
447.97
445.68
328.25
294.40
575.36
478.67
Tax
3.84
3.93
3.80
3.92
20.40
58.84
58.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
391.86
464.16
434.47
320.54
262.92
506.99
414.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
391.86
464.16
434.47
320.54
262.92
506.99
414.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.94
-20.10
7.45
3.81
11.10
9.52
6.22
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
380.92
444.06
441.92
324.35
274.03
516.51
420.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,514.58
4,940.18
4,754.19
4,304.37
4,166.60
3,936.22
3,889.41
Earnings per share (EPS)
0.68
0.8
0.75
0.56
0.44
0.86
0.68
Diluted Earnings per share
0.68
0.8
0.75
0.56
0.44
0.86
0.68
Operating Profit Margin (Excl OI)
7.62%
8.55%
9.32%
8.92%
11.06%
13.07%
13.68%
Gross Profit Margin
15.36%
13.54%
14.94%
14.47%
15.24%
16.54%
17.2%
PAT Margin
10.21%
9.69%
10.16%
8.93%
8.8%
11.29%
11.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -19.88% vs 11.95% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -14.23% vs 0.50% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -18.51% vs 2.97% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -3.75% vs 860.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Jiangsu Kanion Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,837.10
0
3,837.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,837.10
0
3,837.10
Raw Material Cost
1,136.11
0
1,136.11
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
23.13
0
23.13
Selling and Distribution Expenses
1,806.89
0
1,806.89
Other Expenses
56.60
0.00
56.60
Total Expenditure (Excl Depreciation)
3,532.10
0
3,532.10
Operating Profit (PBDIT) excl Other Income
304.99
0.00
304.99
Other Income
119.49
0
119.49
Operating Profit (PBDIT)
616.49
0
616.49
Interest
23.13
0
23.13
Exceptional Items
-3.85
0
-3.85
Gross Profit (PBDT)
2,700.99
0
2,700.99
Depreciation
204.76
0
204.76
Profit Before Tax
384.75
0
384.75
Tax
3.84
0
3.84
Provisions and contingencies
0
0
0.00
Profit After Tax
391.86
0
391.86
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
391.86
0
391.86
Share in Profit of Associates
0
0
0.00
Minority Interest
-10.94
0
-10.94
Other related items
0.00
0.00
0.00
Consolidated Net Profit
380.92
0
380.92
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,514.58
0
4,514.58
Earnings per share (EPS)
0.68
0
0.68
Diluted Earnings per share
0.68
0
0.68
Operating Profit Margin (Excl OI)
7.62%
0%
0.00
7.62%
Gross Profit Margin
15.36%
0%
0.00
15.36%
PAT Margin
10.21%
0%
0.00
10.21%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 383.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -19.88% vs 11.95% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 38.09 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -14.23% vs 0.50% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.70 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -18.51% vs 2.97% in Dec 2023

Annual - Interest
Interest 2.31 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.75% vs 860.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.62%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023